Showing results (61-70 of 107) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2026
HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cellsOliver Cottrell, Andrew Rowntree, Kunal Chopra, et al.Cancer Research|January 14, 2010
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptorHannah Harrison, Gillian Farnie, Sacha J Howell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanismsJagdeep K Singh, Gillian Farnie, Nigel J Bundred, et al.NPJ Breast Cancer|May 29, 2021
FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activitySimon Timbrell, Hosam Aglan, Angela Cramer, et al.BMC Medical Genomics|September 23, 2008
The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosisAndrew H Sims, Graeme J Smethurst, Yvonne Hey, et al.Oncotarget|June 17, 2014
17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cellsPaul K Wright, Sarah Bowen Jones, Nicholas Ardern, et al.Cancers|June 4, 2020
Tailored Functionalized Magnetic Nanoparticles to Target Breast Cancer Cells Including Cancer Stem-Like CellsAna Lazaro-Carrillo, Macarena Calero, Antonio Aires, et al.Oncotarget|September 2, 2015
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cellsRebecca Lamb, Bela Ozsvari, Gloria Bonuccelli, et al.Oncotarget|December 17, 2013
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activityLing Yu, Shiqing Liu, Chun Zhang, et al.Molecular Cancer Research : MCR|October 2, 2019
The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse SignalingLing Yu, Kezhou Xia, Tian Gao, et al.Pageof 11